- The folks at Woman's Health University Hospital, Egypt are studying the effects of Growth hormone (Norditropin, Novo nordisk) on Female Infertility Due to Diminished Ovarian Reserve in females ages 20 years to 45 years. This clinical trial is slated to start September 2013 and is expected to end circa March 2014.01003498919 Dina M Dakhly, MD
|Recruiting||Dina M Dakhly, MDfirstname.lastname@example.org||01003498919|
This study is officially titled, "Which is the Best IVF/ICSI Protocol to be Used in Poor Responders Receiving Growth Hormone as an Adjuvant Treatment ? A Prospective Randomized Study."
|Recruiting||private IVF medical center|
Giza, Cairo, 12311
Egypt - map
|Dina M Dakhly, MD||01003498919|
For more study details, please visit this link to ClinicalTrials.gov record, which is the source of this webpage.